Jane Street Group, LLC Alaunos Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$1.09 - $1.89 $22,890 - $39,690	-21,000 Reduced 50.72%	20,400 $22,000
Q3 2021 Nov 16, 2021	BUY	$1.44 - $2.73 $21,456 - $40,677	14,900 Added 56.23%	41,400 $75,000
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $79,952 - $111,568	-30,400 Reduced 53.43%	26,500 $70,000
Q1 2021 May 18, 2021	BUY	$2.82 - $5.6 $106,596 - $211,680	37,800 Added 197.91%	56,900 $205,000
Q2 2020 Aug 17, 2020	BUY	$2.2 - $3.71 $12,320 - $20,776	5,600 Added 41.48%	19,100 $63,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $200,265 - $271,245	-50,700 Reduced 78.97%	13,500 $64,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $265,146 - $445,548	64,200 New	64,200 $275,000
Q2 2018 Aug 15, 2018	SELL	$3.02 - $4.94 $57,682 - $94,354	-19,100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $66,086 - $98,174	19,100 New	19,100 $75,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.